Every material Form 8-K Averin Capital Acquisition Corp. has filed with the SEC since April 08, 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
On October 16, 2026, Mary Szela resigned from the board of Averin Capital Acquisition Corp. and from its audit and compensation committees, effective the same day, and the filing says the resignation was not due to any disagreement with the company. The board filled the open seats by naming Graeme Bell as compensation committee chairperson and Akiko Moni Miyashita as an audit committee member, both effective October 16, 2026.
Mary Szela resigned from the board, the audit committee and as chair of the compensation committee, effective October 16, 2026.
The filing states her resignation was not the result of any disagreement with the company on operations, policies or practices.
Graeme Bell was appointed compensation committee chairperson and Akiko Moni Miyashita was appointed to the audit committee, both effective October 16, 2026.
Averin Capital Acquisition Corp., a special purpose acquisition company (SPAC), appointed Akiko Moni Miyashita to its board effective immediately on May 28, 2026. She is a former Valo Health and IBM corporate strategy and M&A executive, and she signed a joinder to the company's February 18, 2026 letter agreement, which includes redemption waivers and voting commitments for an initial business combination.
Board appointment made May 28, 2026, effective immediately; Ms. Miyashita will serve in the first class of directors until the first annual general meeting.
Ms. Miyashita, age 70, is founder of Beacon Hill Strategy Group and previously served as Executive Vice President and Chief Strategy Officer of Valo Health, LLC (May 2019 to September 2024).
She signed a joinder to the February 18, 2026 letter agreement, under which signatories agreed to waive certain redemption rights and vote in favor of an initial business combination.
She also signed a joinder to the February 18, 2026 registration rights agreement and entered into a standard director indemnity agreement.
Averin Capital Acquisition Corp., a blank check company, said holders of its IPO units may begin separately trading the Class A ordinary shares and warrants starting April 10, 2026. This is a routine administrative step that does not change the terms of the shares or warrants, but it lets holders trade each component on its own under new symbols.
Separate trading of Class A ordinary shares and warrants begins April 10, 2026.
Separated shares and warrants will trade on Nasdaq Global Market as ACAA and ACAAW; unseparated units continue as ACAAU.
Each unit includes one Class A ordinary share and one-sixth of one redeemable warrant exercisable at $11.50 per share; no fractional warrants will be issued.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Averin Capital Acquisition Corp. filing is on SEC EDGAR ↗. 8-K briefs of other companies →